Performance Sleep, Performance Dose 20 units (1mg Tesamorelin / 200mcg Ipamorelin) Frequency 5 days / week Administration Subcutaneous Timing PM, 60-90 minutes after last meal, close to bedtime Vial Size 12mg (10mg Tesamorelin / 2mg Ipamorelin) Reconstitution 2mL Bacteriostatic Water Cycle Length 3 months on, 2 months off Vials / Month 2 Vials / Cycle 6 Do not combine with other GH-stimulating peptides such as CJC-1295/Ipamorelin
Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
In the body, they act as signaling molecules, influencing processes such as metabolism, hormone production, and cellular repair
Sermorelin injections are subcutaneous (similar to insulin shots), and ReadyRx provides full training materials, video demos, and ongoing support
